Conference Coverage
about 1 hour ago
APSARD 2026: 5 Presentations to Look Out Forabout 1 month ago
Favorable Profile Data On MK-2214 for Treatment of Alzheimer Diseaseabout 1 month ago
"Words Matter": Best Practices in Treating Postpartum DepressionLatest Content
Advertisement
Shorts
2:38
Microdosing: Patient Expectations and Further Research
2 days ago
by
Joseph F. Goldberg, MD(+1 more)
1:11
Bipolar Diagnostic Challenges and Antidepressant Failure
a month ago
by
Manish Zinzuvadia, MD
1:32
Reconsidering Antipsychotics for Delirium
a month ago
by
John J. Miller, MD(+1 more)
1:16
PRiSM Diagnostic Tool: Clinical Writing Opportunity
a month ago
by
Mark L. Ruffalo, MSW, DPsa
1:19
How Digital Apps Avoid FDA Regulation By Claiming No Medical Intent
2 months ago
by
Jon-Patrick Allem, PhD
1:29
Shifting to the Glutamate Model: Insights from SoFlo Psychiatry
2 months ago
by
Juan D. Oms, MD, FAPA
1:43
New Analysis of Prediction Models for Suicide Risk
2 months ago
by
Seena Fazel, MBChB, MD, FRCPsych
1:08
Treating the Whole Patient With Substance Use Disorder
2 months ago
by
Rachel Rohaidy, MD
0:53
Comorbidities With ADHD to Watch Out For
2 months ago
by
Justin Kei, MD
1:15
Impact of Caplyta FDA Approval, Notes from Roger McIntyre, MD, FRCPC
2 months ago
by
Roger S. McIntyre, MD, FRCPC
Digital Edition
Podcasts
All News
Advertisement
Advertisement
Cassava Sciences shares insights from phase 3 trials of simufilam for Alzheimer disease, revealing potential treatment differences despite unmet primary endpoints.
FDA approves ProlivRx, a groundbreaking at-home therapy for major depressive disorder, offering new hope for patients unresponsive to traditional treatments.
Explore the unique mood-stabilizing properties of antiepileptics like lamotrigine, valproic acid, and carbamazepine in bipolar disorder treatment.
Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.
Explore the complex relationship between gender, sexual health, and mental health with insights from expert Eugene T. Lucas Jr, DNP, CRNP, FNP-BC, APMHNP-BC.
Explore the diverse legacies of influential psychiatrists who shaped mental health, from poetry to cooking, highlighting their profound impact on society.
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
Lipocine's LPCN 1154 shows promise in treating postpartum depression, with a strong safety profile and potential for rapid relief in outpatient settings.
Strategies for Improved Collaborative Management of Personality Disorders in Correctional Facilities
Explore the complexities of personality disorders in correctional settings and discover effective treatment strategies for better mental health outcomes.
Emergency departments face challenges in detecting suicidality among trauma patients, highlighting the need for effective screening and intervention strategies.
Explore the evolving language of mental health as it intersects with societal issues, highlighting the importance of the term "upstander" in psychiatry.
Advertisement
Explore the intersection of cultural trauma and mental health, emphasizing the importance of awareness and education in preventing future conflicts.
A clinical trial reveals challenges in assessing schizophrenia symptoms due to cultural and language differences, highlighting the need for improved measurement tools.
Psychiatric Times is excited to embrace change with new digital editions and engaging content, and invite you, our readers, to explore diverse topics across multiple platforms.
Reviva Pharmaceuticals reveals promising clinical trial data on brilaroxazine, highlighting its potential to treat negative symptoms in schizophrenia.
Explore the complex relationship between epilepsy and psychosis, including forced normalization and treatment strategies for affected patients.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs
2
In Memoriam, Epilogue: The Psychiatrist Who Mistook Oliver Sacks for a Psychiatrist Confesses
3
New Useful Insights: Analysis of Data From Phase 3 Clinical Trials Evaluating Simufilam for Mild-to-Moderate Alzheimer Disease
4
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
5